相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
Wei Zhang et al.
DEVELOPMENTAL CELL (2022)
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Simona Serrati et al.
MOLECULAR CANCER (2022)
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity
Daisuke Sugiura et al.
NATURE IMMUNOLOGY (2022)
Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy
Shiyang Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)
Immune cell-derived small extracellular vesicles in cancer treatment
Sung-Jin Choi et al.
BMB REPORTS (2022)
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1
Meizhang Li et al.
JOURNAL OF EXTRACELLULAR VESICLES (2021)
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
Yufan Qiu et al.
ONCOGENE (2021)
Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1
Michael Timaner et al.
ONCOGENE (2020)
Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
Marine Cordonnier et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Exosomes derived from exhausted CD8+T cells impaired the anticancer function of normal CD8+T cells
Xiaochen Wang et al.
JOURNAL OF MEDICAL GENETICS (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses
Daisuke Sugiura et al.
SCIENCE (2019)
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
Yunlong Zhao et al.
IMMUNITY (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry
Ye Tian et al.
ACS NANO (2018)
Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients
M-N Theodoraki et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
Yunlong Zhao et al.
CELL REPORTS (2018)
PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
Apoorvi Chaudhri et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Regulation of immune responses by extracellular vesicles
Paul D. Robbins et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80
Samuel T. Haile et al.
JOURNAL OF IMMUNOLOGY (2011)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Ezra E. W. Cohen
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
分享论文
